Detalles de la búsqueda
1.
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Lancet
; 403(10424): 365-378, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224710
2.
Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
J Infect Dis
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38438123
3.
Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial.
Lancet
; 401(10381): 1020-1036, 2023 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913959
4.
Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
N Engl J Med
; 383(23): 2242-2254, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264546
5.
Diagnostic Performance of Loop-Mediated Isothermal Amplification and Ultrasensitive Rapid Diagnostic Tests for Malaria Screening Among Pregnant Women in Kenya.
J Infect Dis
; 226(4): 696-707, 2022 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35811308
6.
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Antimicrob Agents Chemother
; 66(9): e0020722, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036611
7.
Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
Malar J
; 21(1): 265, 2022 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100912
8.
Novel application of one-step pooled molecular testing and maximum likelihood approaches to estimate the prevalence of malaria parasitaemia among rapid diagnostic test negative samples in western Kenya.
Malar J
; 21(1): 319, 2022 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36336700
9.
Impact of Community-Based Mass Testing and Treatment on Malaria Infection Prevalence in a High-Transmission Area of Western Kenya: A Cluster Randomized Controlled Trial.
Clin Infect Dis
; 72(11): 1927-1935, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324850
10.
Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy.
Antimicrob Agents Chemother
; 65(3)2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33361303
11.
Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum.
Malar J
; 20(1): 92, 2021 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593329
12.
Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya.
Clin Infect Dis
; 71(4): 1063-1071, 2020 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31555824
13.
Evaluation of the colorimetric malachite green loop-mediated isothermal amplification (MG-LAMP) assay for the detection of malaria species at two different health facilities in a malaria endemic area of western Kenya.
Malar J
; 19(1): 329, 2020 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907582
14.
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.
Malar J
; 19(1): 291, 2020 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32795367
15.
Modelling the relationship between malaria prevalence as a measure of transmission and mortality across age groups.
Malar J
; 18(1): 247, 2019 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31337411
16.
Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned.
Malar J
; 18(1): 255, 2019 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31357997
17.
Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trial.
Malar J
; 16(1): 240, 2017 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28592250
18.
Mass testing and treatment on malaria in an area of western Kenya.
Clin Infect Dis
; 72(6): 1103-1104, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564080
19.
Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
Clin Infect Dis
; 62(3): 323-333, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26486699
20.
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
Lancet
; 386(10012): 2507-19, 2015 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429700